Long-term outcomes and predictors of response to rituximab in anti-MAG neuropathy: a multicenter real-world study. Delmont E, Cintas P, Tard C, Boucraut J, Magy L, Frachet S, Labeyrie C, Echaniz-Laguna A, Noel N, Svahn J, et al. J Neurol. 2026 Nov 05; 273(11). PMID: 42986466. Abstract CommentRecommendBookmarkWatch